WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 30, 2005, 25(48):11165-11174; doi:10.1523/JNEUROSCI.4031-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, X.-K.
Right arrow Articles by Hamel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, X.-K.
Right arrow Articles by Hamel, E.

 Previous Article  |  Next Article 

Neurobiology of Disease
Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease

Xin-Kang Tong, Nektaria Nicolakakis, Ara Kocharyan, and Edith Hamel

Laboratory of Cerebrovascular Research, Montreal Neurological Institute, McGill University, Montréal, Québec, Canada H3A 2B4

The roles of oxidative stress and structural alterations in the cerebrovascular dysfunctions associated with Alzheimer's disease (AD) were investigated in transgenic mice overexpressing amyloid precusor protein (APP+) or transforming growth factor-{beta}1 (TGF+). Age-related impairments and their in vitro reversibility were evaluated, and underlying pathogenic mechanisms were assessed and compared with those seen in AD brains. Vasoconstrictions to 5-HT and endothelin-1 were preserved, except in the oldest (18-21 months of age) TGF+ mice. Despite unaltered relaxations to sodium nitroprusside, acetylcholine (ACh) and calcitonin gene-related peptide-mediated dilatations were impaired, and there was an age-related deficit in the basal availability of nitric oxide (NO) that progressed more gradually in TGF+ mice. The expression and progression of these deficits were unrelated to the onset or extent of thioflavin-S-positive vessels. Manganese superoxide dismutase (SOD2) was upregulated in pial vessels and around brain microvessels of APP+ mice, pointing to a role of superoxide in the dysfunctions elicited by amyloidosis. In contrast, vascular wall remodeling associated with decreased levels of endothelial NO synthase and cyclooxygenase-2 and increased contents of vascular endothelial growth factor and collagen-I and -IV characterized TGF+ mice. Exogenous SOD or catalase normalized ACh dilatations and NO availability in vessels from aged APP+ mice but had no effect in those of TGF+ mice. Increased perivascular oxidative stress was not evidenced in AD brains, but vascular wall alterations compared well with those seen in TGF+ mice. We conclude that brain vessel remodeling and associated alterations in levels of vasoactive signaling molecules are key contributors to AD cerebrovascular dysfunctions.

Key words: amyloid-{beta}; transforming growth factor-{beta}1; transgenic mouse models; cerebral blood vessels; superoxide dismutase; vascular endothelial growth factor


Received June 3, 2005; accepted October 15, 2005.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
B. H. Han, M.-l. Zhou, F. Abousaleh, R. P. Brendza, H. H. Dietrich, J. Koenigsknecht-Talboo, J. R. Cirrito, E. Milner, D. M. Holtzman, and G. J. Zipfel
Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-{beta} Peptide, Partial Restoration via {gamma}-Secretase Inhibition
J. Neurosci., December 10, 2008; 28(50): 13542 - 13550.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Nicolakakis, T. Aboulkassim, B. Ongali, C. Lecrux, P. Fernandes, P. Rosa-Neto, X.-K. Tong, and E. Hamel
Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor {gamma} Agonist
J. Neurosci., September 10, 2008; 28(37): 9287 - 9296.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L.-P. Bernier, A. R. Ase, X. Tong, E. Hamel, D. Blais, Q. Zhao, D. E. Logothetis, and P. Seguela
Direct Modulation of P2X1 Receptor-Channels by the Lipid Phosphatidylinositol 4,5-Bisphosphate
Mol. Pharmacol., September 1, 2008; 74(3): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. P. Meyer, A. Ulmann-Schuler, M. Staufenbiel, and T. Krucker
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
PNAS, March 4, 2008; 105(9): 3587 - 3592.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, et al.
Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
PNAS, January 29, 2008; 105(4): 1347 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
E. Hamel, N. Nicolakakis, T. Aboulkassim, B. Ongali, and X-K. Tong
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease
Exp Physiol, January 1, 2008; 93(1): 116 - 120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X.-K. Tong and E. Hamel
Transforming Growth Factor-beta1 Impairs Endothelin-1-Mediated Contraction of Brain Vessels by Inducing Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 and Inhibiting p38 MAP Kinase
Mol. Pharmacol., December 1, 2007; 72(6): 1476 - 1483.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
J. Neurosci., May 10, 2006; 26(19): 5167 - 5179.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-